Erik Serrao, PhD, discusses the HemoTypeSC test, which provides a rapid, cost-effective screening method for sickle cell disease in newborns living in limited-resource settings.
Editor's note: On March 11, 2019, the editors of Blood retracted this abstract, after a co-author stated it was submitted without his consent.